Activating mGlu3 metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus.
S. Dogra, B. J. Stansley, Z. Xiang, W. Qian, R. G. Gogliotti, F. Nicoletti, C. W. Lindsley, C. M. Niswender, M. E. Joffe, P. J. Conn
Abstract
BackgroundPolymorphisms in GRM3, the gene encoding the mGlu3 metabotropic glutamate receptor, are associated with impaired cognition and neuropsychiatric disorders such as schizophrenia. Limited availability of selective genetic and molecular tools has hindered progress in developing a clear understanding of the mechanisms through which mGlu3 receptors regulate synaptic plasticity and cognition. MethodsWe examined associative learning in mice with trace fear conditioning, a hippocampal-dependent learning task disrupted in patients with schizophrenia. Underlying cellular mechanisms were assessed using ex vivo hippocampal slice preparations with selective pharmacological tools and selective genetic deletion of mGlu3 receptor expression in specific neuronal subpopulations. ResultsmGlu3 receptor activation enhanced trace fear conditioning and reversed deficits induced by subchronic phencyclidine. Mechanistic studies revealed that mGlu3 receptor activation induced metaplastic changes, biasing afferent stimulation to induce long-term potentiation through a mGlu5 receptor-dependent, endocannabinoid-mediated, disinhibitory mechanism. Selective genetic deletion of either mGlu3 or mGlu5 from hippocampal pyramidal cells eliminated effects of mGlu3 activation, revealing a novel mechanism by which mGlu3 and mGlu5 interact to enhance cognitive function. ConclusionsThese data demonstrate that activation of mGlu3 receptors in hippocampal pyramidal cells enhances hippocampal-dependent cognition in control and impaired mice by inducing a novel form of metaplasticity to regulate circuit function - providing a clear mechanism through which genetic variation in GRM3 can contribute to cognitive deficits. Developing approaches to positively modulate mGlu3 receptor function represents an encouraging new avenue for treating cognitive disruption in schizophrenia and other psychiatric diseases.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modulation of hippocampal network oscillation by PICK1-dependent cell surface expression of mGlu3 receptors
Pola Tuduri, Nathalie Bouquier, … Jeanne Ster·Journal of NeurosciencePeer-reviewed·Oct 6, 2022
- An unsuspected physiological role for mGluRIII glutamate receptors in hippocampal area CA1
Maurice A. Petroccione, Marcello Melone, … Annalisa Scimemi·Cell ReportsPeer-reviewed·May 28, 2026
- Activation of mGlu2 receptors reverses persistent post-methamphetamine deficit in object-in-place recognition memory.
Viktoria Galbava, Lizhen Wu, Marek Schwendt·bioRxiv·May 28, 2026
- D1-like receptor activation rescues hippocampal synaptic plasticity and cognitive impairments in the MK-801 schizophrenia model.
Melissa Hernández‐Frausto, Emilio J. Galván, Carolina López‐Rubalcava·Behavioural Brain ResearchPeer-reviewed·Sep 12, 2024
- Systemic administration of the mGluR2/3 antagonist LY341495 disrupts reward-related behaviors across ingestive and social domains in mice
Hiroto Inoue, Mizuki Yamamoto, … Koji Toda·Translational PsychiatryPeer-reviewed·Sep 16, 2026
- Brain-region-specific changes and dysregulation of activity regulated genes in Gria3 mutant mice, a genetic animal model of schizophrenia
Wei-Chao Huang, Ryan J. Kast, … Morgan Sheng·bioRxiv·Nov 15, 2024